RBGPF
0.1000
A major accident occurred at the launch ceremony for a new North Korean naval destroyer, state media reported Thursday, with leader Kim Jong Un calling the mishap a "criminal act".
Two Israeli embassy staffers were shot dead late Wednesday outside a Jewish museum in Washington by a gunman who shouted "free Palestine," authorities said, with US and Israeli leaders expressing shock and outrage over the killings.
Two Israeli embassy staffers were shot dead late Wednesday outside a Jewish museum in Washington by a gunman who shouted "free Palestine," authorities said, with US officials and Israeli diplomats expressing shock and outrage over the killings.
Sitting together on the classroom floor in Kalyanpur in northwest India, a dozen children aged five and six are trying to identify Hindi words beginning with the "p" sound.
Hundreds of young Mongolians turned out this week in the country's capital calling for the prime minister's resignation on allegations of corruption, a longstanding source of deep public anger in the landlocked democracy.
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 22, 2025 / New to The Street, one of the nation's most widely viewed business media platforms, has announced a high-profile partnership with Skip Barber Racing School, America's premier motorsports education brand, and Stables Motor Condos, Georgia's elite luxury garage community.
VANCOUVER, BC / ACCESS Newswire / May 22, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that the Membership Interest Purchase Agreement (the "MIPA") entered into by its wholly owned subsidiary, FN Pharmaceuticals, and Mr. Caleb Zobrist (the "Seller") to acquire his nine percent (9%) of the issued and outstanding membership interests of Alternative Medicine Association LC ("AMA") has been amended (refer to news release dated April 8, 2024).
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.
Sixteen European consumer groups on Wednesday called on the European Union to take action against seven low-cost airlines over their baggage fees.
A member of Irish rap group Kneecap has been charged with a terror offence for allegedly displaying a Hezbollah flag at a London concert, police said on Wednesday.
A Vietnamese court on Wednesday jailed 23 officials and business people over the illegal exploitation and export of rare earths.
French President Emmanuel Macron's political party wants to ban minors under 15 from wearing the Muslim headscarf in public, with the government set to review a report Wednesday on the spread of "political Islamism" in France.
British clothes-to-food retailer Marks and Spencer on Wednesday said a cyberattack disrupting its online service is set to last through to July and hit group profit by around £300 million ($404 million).
Fast-moving floodwaters rose Wednesday in eastern Australia, inundating homes and leaving residents stranded on their roofs overnight, as authorities warned more rain was expected in coming days.
Perched 45 metres (148 feet) high, young apprentice electricians replace a connection atop a pylon. In the UK, National Grid recruitment is at full power as its electricity network adapts for renewables.
Strategic media partnership will amplify AINOS's brand and innovation story across major financial networks and digital platforms
A new study has revealed that conventional meat-based pet food carries a largely unrecognized environmental cost - contributing significantly to land use, greenhouse gas (GHG) emissions, and climate breakdown. The review, just published, found that pet food production is closely tied to the livestock industry, which is responsible for at least one-fifth of annual global GHG emissions.
Investment from largest shareholder strengthens balance sheet, signals insider conviction, and funds Telomir-1's upcoming IND submission for a rare disease indication
AUSTIN, TEXAS / ACCESS Newswire / May 21, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it has updated its investor FAQ's on its investor website in response to shareholder questions around its AGM date and other corporate actions.
SAN FRANCISCO, CA / ACCESS Newswire / May 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company"), today announced that it has entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 per share in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company agreed to issue to investors unregistered warrants to purchase up to 492,612 shares of common stock at an exercise price of $5.84 per share that will be immediately exercisable upon issuance and will expire on the earlier of (i) 24 months from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event. The closing of the offering is expected to occur on or about May 22, 2025, subject to the satisfaction of customary closing conditions.
NEWARK, CA / ACCESS Newswire / May 21, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies Global Healthcare Conference taking place June 3-5, 2025, in New York, NY. The Company will also participate in one-on-one meetings.
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA) for mRNA-1083, its flu/COVID combination vaccine candidate for adults aged 50 years and older. The Company plans to resubmit the BLA later this year, after vaccine efficacy data from the ongoing Phase 3 trial of its investigational seasonal influenza vaccine, mRNA-1010, are available. Moderna continues to expect interim data from the mRNA-1010 trial to be available this summer.
The mother of Sean "Diddy" Combs's ex-partner Cassie testified Tuesday about threats and violence experienced by her daughter during her decade-long relationship with the music mogul.
Portuguese police announced Tuesday the recovery of the Women's Champions League trophy after it was stolen from the Estadio Jose Alvalade in Lisbon, which will host the upcoming final between holders Barcelona and Arsenal.
The father of one of two Mexican cadets killed when a naval sailing ship crashed into New York's Brooklyn Bridge paid tribute to his daughter as a "wonderful" person Tuesday.
Chess legend Magnus Carlsen, considered one of the best players in history, has been held to a draw by a team of 143,000 opponents in an online match.
Germany saw a 40 percent jump in politically motivated crime last year, official data showed Tuesday, with the federal police chief warning of a growing "radicalisation in society".
The mother of jailed Egyptian-British activist Alaa Abdel Fattah announced on Tuesday that she was returning to a full hunger strike to protest against her son's lengthy imprisonment in Egypt.
Twin Gazan filmmakers Arab and Tarzan Nasser said they never thought the title of their new film "Once Upon A Time In Gaza" would have such heartbreaking resonance.
As announced, initial proof-of-concept (POC) results from distinct ongoing investigator-initiated trial (IIT) in Abu Dhabi show crofelemer reduced total parenteral support in a pediatric MVID patient with intestinal failure by up to 27%; per the IIT protocol, patient was taken off crofelemer after 12 weeks of treatment for a period of 30 days, but was restarted on daily crofelemer treatment after just 8 days, as patient's symptoms were worseningAdditional POC IIT results expected throughout 2025 for MVID; results from company's MVID Phase 2 study expected with completion of treatment in H2 2026Ground-breaking results in single-digit number of MVID patients could potentially lead to expedited approval in the EU through PRIME and to Breakthrough Therapy designation in the US
Trial marks key milestone in driving pipeline progressPhase 1 trial scheduled for completion mid-June 2025Topline data from High-Dose Aspirin Trail anticipated early in 3Q with the potential to support an accelerated approval, subject to FDA feedback
Company Updates Investor Presentation to Reflect Strong Q1 Earnings, More than $20M in Pro Forma Revenue and 15% Increase in 2025 Pro Forma Revenue Guidance